BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27184093)

  • 21. Analytical performance of a bronchial genomic classifier.
    Hu Z; Whitney D; Anderson JR; Cao M; Ho C; Choi Y; Huang J; Frink R; Smith KP; Monroe R; Kennedy GC; Walsh PS
    BMC Cancer; 2016 Feb; 16():161. PubMed ID: 26920854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using Bronchoscopic Lung Cryobiopsy and a Genomic Classifier in the Multidisciplinary Diagnosis of Diffuse Interstitial Lung Diseases.
    Kheir F; Alkhatib A; Berry GJ; Daroca P; Diethelm L; Rampolla R; Saito S; Smith DL; Weill D; Bateman M; Abdelghani R; Lasky JA
    Chest; 2020 Nov; 158(5):2015-2025. PubMed ID: 32464189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electromagnetic navigation bronchoscopy to access lung lesions in 1,000 subjects: first results of the prospective, multicenter NAVIGATE study.
    Khandhar SJ; Bowling MR; Flandes J; Gildea TR; Hood KL; Krimsky WS; Minnich DJ; Murgu SD; Pritchett M; Toloza EM; Wahidi MM; Wolvers JJ; Folch EE;
    BMC Pulm Med; 2017 Apr; 17(1):59. PubMed ID: 28399830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Gene Expression Classifier from Whole Blood Distinguishes Benign from Malignant Lung Nodules Detected by Low-Dose CT.
    Kossenkov AV; Qureshi R; Dawany NB; Wickramasinghe J; Liu Q; Majumdar RS; Chang C; Widura S; Kumar T; Horng WH; Konnisto E; Criner G; Tsay JJ; Pass H; Yendamuri S; Vachani A; Bauer T; Nam B; Rom WN; Showe MK; Showe LC
    Cancer Res; 2019 Jan; 79(1):263-273. PubMed ID: 30487137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial.
    Silvestri GA; Tanner NT; Kearney P; Vachani A; Massion PP; Porter A; Springmeyer SC; Fang KC; Midthun D; Mazzone PJ;
    Chest; 2018 Sep; 154(3):491-500. PubMed ID: 29496499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EBUS-TBNA for the diagnosis of central parenchymal lung lesions not visible at routine bronchoscopy.
    Tournoy KG; Rintoul RC; van Meerbeeck JP; Carroll NR; Praet M; Buttery RC; van Kralingen KW; Rabe KF; Annema JT
    Lung Cancer; 2009 Jan; 63(1):45-9. PubMed ID: 18514365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Evaluation of Diagnostic Yield From Bronchoscopy: The Impact of Clinical/Radiographic Factors, Procedure Type, and Degree of Suspicion for Cancer.
    Silvestri GA; Bevill BT; Huang J; Brooks M; Choi Y; Kennedy G; Lofaro L; Chen A; Rivera MP; Tanner NT; Vachani A; Yarmus L; Pastis NJ
    Chest; 2020 Jun; 157(6):1656-1664. PubMed ID: 31978428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electromagnetic navigation bronchoscopy for lung nodule evaluation. Patient selection, diagnostic variables and safety.
    Andersen FD; Degn KB; Riis Rasmussen T
    Clin Respir J; 2020 Jun; 14(6):557-563. PubMed ID: 32052591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of a prospective, multicenter, global, cohort study of electromagnetic navigation bronchoscopy.
    Folch EE; Bowling MR; Gildea TR; Hood KL; Murgu SD; Toloza EM; Wahidi MM; Williams T; Khandhar SJ
    BMC Pulm Med; 2016 Apr; 16(1):60. PubMed ID: 27113209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shared Gene Expression Alterations in Nasal and Bronchial Epithelium for Lung Cancer Detection.
    AEGIS Study Team
    J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 28376173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic yield of electromagnetic navigation bronchoscopy is highly dependent on the presence of a Bronchus sign on CT imaging: results from a prospective study.
    Seijo LM; de Torres JP; Lozano MD; Bastarrika G; Alcaide AB; Lacunza MM; Zulueta JJ
    Chest; 2010 Dec; 138(6):1316-21. PubMed ID: 20435658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combining bronchoscopy and positron emission tomography for the diagnosis of the small pulmonary nodule < or = 3 cm.
    Chhajed PN; Bernasconi M; Gambazzi F; Bubendorf L; Rasch H; Kneifel S; Tamm M
    Chest; 2005 Nov; 128(5):3558-64. PubMed ID: 16306037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial Pneumonia.
    Richeldi L; Scholand MB; Lynch DA; Colby TV; Myers JL; Groshong SD; Chung JH; Benzaquen S; Nathan SD; Davis JR; Schmidt SL; Hagmeyer L; Sonetti D; Hetzel J; Criner GJ; Case AH; Ramaswamy M; Calero K; Gauhar UA; Patel NM; Lancaster L; Choi Y; Pankratz DG; Walsh PS; Lofaro LR; Huang J; Bhorade SM; Kennedy GC; Martinez FJ; Raghu G
    Am J Respir Crit Care Med; 2021 Jan; 203(2):211-220. PubMed ID: 32721166
    [No Abstract]   [Full Text] [Related]  

  • 34. Close Surveillance with Long-Term Follow-up of Subjects with Preinvasive Endobronchial Lesions.
    van Boerdonk RA; Smesseim I; Heideman DA; Coupé VM; Tio D; Grünberg K; Thunnissen E; Snijders PJ; Postmus PE; Smit EF; Daniels JM; Sutedja TG
    Am J Respir Crit Care Med; 2015 Dec; 192(12):1483-9. PubMed ID: 26275031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of scintigraphy with technetium-99m depreotide in the diagnosis and management of patients with suspected lung cancer.
    Axelsson R; Herlin G; Bååth M; Aspelin P; Kölbeck KG
    Acta Radiol; 2008 Apr; 49(3):295-302. PubMed ID: 18365818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishing the diagnosis of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
    Rivera MP; Mehta AC; Wahidi MM
    Chest; 2013 May; 143(5 Suppl):e142S-e165S. PubMed ID: 23649436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation.
    Tanner NT; Porter A; Gould MK; Li XJ; Vachani A; Silvestri GA
    Chest; 2017 Aug; 152(2):263-270. PubMed ID: 28115167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative flexible bronchoscopy in patients with persistent ground-glass nodule.
    Jhun BW; Um SW; Suh GY; Chung MP; Kim H; Kwon OJ; Lee KS; Han J; Kim J
    PLoS One; 2015; 10(3):e0121250. PubMed ID: 25803430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation and management of solitary and multiple pulmonary nodules.
    Viggiano RW; Swensen SJ; Rosenow EC
    Clin Chest Med; 1992 Mar; 13(1):83-95. PubMed ID: 1582151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.